Tag:
Ariad
Latest Headlines
Latest Headlines
FDA panel backs GSK's Votrient for soft-tissue sarcoma
Good news came for GlaxoSmithKline ( $GSK ) Tuesday after the FDA's Oncologic Drugs Advisory Committee voted 11 to 2 in favor of approving Votrient to treat patients with advanced soft tissue sarcoma who have received prior chemotherapy. The FDA approved Votrient in 2009 to treat advanced renal cell carcinoma.
